A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney: Interrelationships between growth factors that regulate EMT in the adult kidney

Nephron - Experimental Nephrology

Volumn 104, Issue 4, 2006, Pages

  Wahab, Nadia A ^a   Mason, Roger M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bone morphogenic protein 7; Connective tissue growth factor; Epithelial to mesenchymal transition; Hepatocyte growth factor; Transforming growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; ION CHANNEL; OSTEOGENIC PROTEIN 1; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; CELL DAMAGE; CELL TRANSFORMATION; CHRONIC KIDNEY DISEASE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE CONTROL; GENE REPRESSION; HUMAN; KIDNEY; KIDNEY TUBULE; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; EPITHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESODERM; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845350114     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094963     Document Type: Short Survey

References (56)

1. Boyer B, Thiery JP: Epithelium-mesenchyme interconversion as example of epithelial plasticity. APMIS 1993;101:257-268.
2. Horster MF, Braun GS, Huber SM: Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 1999;79:1157-1191.
3. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992-994.
4. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
5. Zavadil J, Bottinger EP: TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005;24:5764-5774.
6. Iwano M, Plieth D, Danoff TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-350.
7. Strutz F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
8. Rastaldi MP, Ferrario F, Giardino L, et al: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002;62:137-146.
9. Jinde K, Nikolic-Paterson DJ, et al: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001;38:761-769.
10. Vongwiwatana A, Tasanarong A, Rayner DC, et al: Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant. 2005;5:1367-1374.
11. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
12. Zeisberg M, Bonner G, Maeshima Y, et al: Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001;159:1313-1321.
13. Cheng S, Lovett DH: Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003;162:1937-1949.
14. Yokota Y, Mori S: Role of Id family proteins in growth control. J Cell Physiol 2002;190:21-28.
15. Grotendorst GR, Okochi H, Hayashi N: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996;7:469-480.
16. Wahab NA, Mason RM: Connective tissue growth factor and renal diseases: some answers, more questions. Curr Opin Nephrol Hypertens 2004;13:53-58.
17. Wahab NA, Weston BS, Mason RM: Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp Cell Res 2005;307:305-314.
18. Grotendorst GR, Rahmanie H, Duncan MR: Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 2004;18:469-479.
19. Phanish MK, Wahab NA, Colville-Nash P, et al: The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 2006;393:601-607.
20. Yokoi H, Mukoyama M, Nagae T, et al: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004;15:1430-1440.
21. Higgins DF, Lappin DW, Kieran NE, et al: DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition. Kidney Int 2003;64:2079-2091.
22. Zhang C, Meng X, Zhu Z, et al: Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol Int 2004;28:863-873.
23. Okada H, Kikuta T, Kobayashi T, et al: Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005;16:133-143.
24. Terzi F, Burtin M, Hekmati M, et al: Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 2000;106:225-234.
25. Strutz F, Zeisberg M, Ziyadeh FN, et al: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002;6:1714-1728.
26. Yamate J, Kuribayashi M, Kuwamura M, et al: Differential immunoexpressions of cytoskeletons in renal epithelial and interstitial cells in rat and canine fibrotic kidneys, and in kidney-related cell lines under fibrogenic stimuli. Exp Toxicol Pathol 2005;57:135-147.
27. Strutz F, Zeisberg M, Hemmerlein B, et al: Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int 2000;57:1521-1538.
28. Bates RC, Mercurio AM: Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 2003;14:1790-1800.
29. Rodriguez-Vita J, Sanchez-Lopez E, Esteban V, et al: Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005;111:2509-2517.
30. Yang J, Dai C, Liu Y: Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002;13:2464-2477.
31. Fan JM, Huang XR, Ng YY, et al: Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001;37:820-831.
32. Nightingale J, Patel S, Suzuki N, et al: Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cellmyofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 2004;15:21-32.
33. Li JH, Wang W, Huang XR, et al: Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 2004;164:1389-1397.
34. Yang J, Dai C, Liu Y: A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005;16:68-78.
35. Inoue T, Okada H, Kobayashi T, et al: Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 2003;17:268-270.
36. Dai C, Liu Y: Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004;15:1402-1412.
37. Vukicevic S, Kopp JB, Luyten FP, et al: Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 1996;93:9021-9026.
38. Zeisberg M, Hanai J, Sugimoto H, et al: BMP-7 counteracts TGF-beta1-induced epithelialto-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
39. Zeisberg M, Bottiglio C, Kumar N, et al: Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003;285:F1060-F1067.
40. Kowanetz M, Valcourt U, Bergstrom R: Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004;24:4241-4254.
41. Wang S, Hirschberg R: Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 2004;279:23200-23206.
42. Naldini L, Vigna E, Bardelli A, et al: Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem 1995;270:603-611.
43. Zeisberg M, Shah AA, Kalluri R: Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005;280:8094-8100.
44. Benchabane H, Wrana JL: GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 2003;23:6646-6661.
45. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K: Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001;276:12477-12480.
46. Ulloa L, Doody J, Massague J: Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999;397:710-713.
47. Fukasawa H, Yamamoto T, Togawa A, et al: Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci USA. 2004;101:8687-8692.
48. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002;13:1464-1472.
49. Ionescu AM, Drissi H, Schwarz Em, et al: CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter. J Cell Physiol 2004;198:428-440.
50. Bai S, Shi X, Yang X, et al: Smad6 as a transcriptional corepressor. J Biol Chem 2000;275:8267-8270.
51. Hata A, Lagna G, Massague J, et al: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 1998;12:186-197.
52. Lin X, Liang YY, Sun B, et al: Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol Cell Biol 2003;23:9081-9093.
53. Wahab NA, Weston BS, Mason RM: Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 2005;16:340-351.
54. Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR 3rd, Carmichael DF: The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 2001;276:40659-40667.
55. Babic AM, Chen CC, Lau LF: Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999;19:2958-2966.
56. Abreu JG, Ketpura NI, Reversade B, et al: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002;4:599-604.